Megestrol acetate used as primary hormonal therapy in stage D prostatic cancer

Seminars in Oncology

Volumn 12, Issue 1 SUPPL. 1, 1985, Pages 36-39

  Bonomi, P ^a   Pessis, D ^a   Bunting, N ^a   Block, M ^b   Anderson, K ^b   Wolter, J ^b   Rossof, A ^b   Slayton, R ^b   Harris, J ^b  

^a RUSH MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MEGESTROL ACETATE;

ADVERSE DRUG REACTION; ASEPTIC NECROSIS; BONE; CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CUSHINGOID SYNDROME; DRUG EFFICACY; DRUG THERAPY; FLUID RETENTION; HUMAN; MALE GENITAL SYSTEM; ORAL DRUG ADMINISTRATION; PROSTATE CARCINOMA; THERAPY; WEIGHT GAIN;

AGED; HUMANS; MALE; MEGESTROL; MEGESTROL ACETATE; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 0022362068     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)